发明名称 FORMULATION FOR TREATMENT OF MIGRAINE
摘要 PROBLEM TO BE SOLVED: To provide a system applicable to needle-free delivery which comprises a sustained release formulation for the treatment of migraine which is debilitating neurological disease, related head pain such as cluster headache and the symptoms.SOLUTION: A system comprises: a drug delivery device; and a biphasic formulation which is comprised of a first component which provides a fast acting pain alleviation effect within one hour or less, and a second component which has high viscosity and provides a long term alleviation effect over a period of 4 hours or more. The drug delivery device is a needle-free injector, and the second component is composed of a carrier which provides controlled release of a drug over a period of 4 hours or more. The system comprises: a drug as the first component selected from the group consisting of sumatriptan, almotriptan, rizatriptan, eletriptan and zomitriptan; and a drug as the second component selected from the group consisting of naratriptan and frovatriptan.
申请公布号 JP2014129365(A) 申请公布日期 2014.07.10
申请号 JP20140020406 申请日期 2014.02.05
申请人 ZOGENIX INC 发明人 FARR STEPHEN J;JOHN TURANIN;ROGER HAWLEY;JEFFREY A SCHUSTER
分类号 A61K45/06;A61K9/10;A61K31/403;A61K31/404;A61K31/4045;A61K31/4178;A61K31/4196;A61K31/422;A61K31/439;A61K31/454;A61K47/12;A61K47/24;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/42;A61P1/08;A61P25/04;A61P25/06;A61P43/00 主分类号 A61K45/06
代理机构 代理人
主权项
地址